Measured in serum, they can serve as biomarkers and there is a study that has determined the level of miR-146a in the serum of T2D patients as one of the microRNAs of a set of 7 microRNAs considered to act as key regulators of the expression, production, secretion or effectiveness of insulin [38]. This evidence concerns the gene INS and type 2 diabetes mellitus.